These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 6669444)
1. Hepatitis a virus antibody in chronic diffuse liver disease. Dávid K; Halmy L Acta Med Hung; 1983; 40(2-3):147-53. PubMed ID: 6669444 [TBL] [Abstract][Full Text] [Related]
2. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease. Dávid K; Halmy L Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241 [TBL] [Abstract][Full Text] [Related]
3. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India? Anand AC; Nagpal AK; Seth AK; Dhot PS J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855 [TBL] [Abstract][Full Text] [Related]
4. Vaccination for hepatitis A virus is not required for patients with chronic liver disease in India. Acharya SK; Batra Y; Saraya A; Hazari S; Dixit R; Kaur K; Bhatkal B; Ojha B; Panda SK Natl Med J India; 2002; 15(5):267-8. PubMed ID: 12502138 [TBL] [Abstract][Full Text] [Related]
5. Exposure to HAV infection in patients with chronic liver disease in Italy, a multicentre study. Sagnelli E; Stroffolini T; Almasio P; Mele A; Coppola N; Ferrigno L; Scolastico C; Onofrio M; Imparato M; Filippini P J Viral Hepat; 2006 Jan; 13(1):67-71. PubMed ID: 16364085 [TBL] [Abstract][Full Text] [Related]
6. Susceptibility to hepatitis A virus infection among chronic liver disease patients and healthy blood donors in Thailand. Pramoolsinsap C; Attamasirul K; Busagorn N; Maneerat Y; Nuchprayoon C; Tanprasert S; Srivatanakul P; Theamboonlers A; Hirsch P; Poovorawan Y Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):91-5. PubMed ID: 10695795 [TBL] [Abstract][Full Text] [Related]
7. Screening for hepatitis A and B antibodies in patients with chronic liver disease. Lau DT; Hewlett AT Am J Med; 2005 Oct; 118 Suppl 10A():28S-33S. PubMed ID: 16271538 [TBL] [Abstract][Full Text] [Related]
8. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination. Hussain Z; Das BC; Husain SA; Murthy NS; Kar P J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of hepatitis A virus antibodies in patients with chronic liver diseases. López Serrano A; Antón Conejero MD; Alcaraz Soriano MJ; García del Castillo G; Gómez Pajares F; Moreno-Osset E Rev Esp Enferm Dig; 2000 Aug; 92(8):508-17. PubMed ID: 11084818 [TBL] [Abstract][Full Text] [Related]
10. [Frequency of antigen associated to hepatitis due to virus B (HBAg) and of antibody (HBAc) in healthy subjects and during of course of acute and chronic hepatitis. Radioimmunologic study]. Realdi G; Tremolada F; Alberti A; Rigoli A; Diodati G; Visconti M Quad Sclavo Diagn; 1975 Jun; 11(2):419-30. PubMed ID: 1223946 [TBL] [Abstract][Full Text] [Related]
11. [e/Anti-e system in liver disease]. Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis A virus infection in Taiwan. A hospital-based study. Sung JL; Chen DS; Yu JU; Wang TH; Lay MY; Wang CY; Lai MS Trop Geogr Med; 1980 Dec; 32(4):324-8. PubMed ID: 6259786 [TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of hepatitis A virus antibody in patients with chronic liver disease--experience from a tertiary care hospital in north India. Dhotial A; Kapoor D; Kumar N Trop Gastroenterol; 2002; 23(4):170-1. PubMed ID: 12833702 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and presentation of hepatitis C related chronic liver disease in southern India. Issar SK; Ramakrishna BS; Ramakrishna B; Christopher S; Samuel BU; John TJ J Trop Med Hyg; 1995 Jun; 98(3):161-5. PubMed ID: 7783272 [TBL] [Abstract][Full Text] [Related]
15. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus? Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334 [TBL] [Abstract][Full Text] [Related]
16. [The incidence of antibodies against hepatitis A virus in various age groups in the Basle population 1978-79]. Stadelmann W; Gasser M; Löffler H Schweiz Med Wochenschr; 1980 Jun; 110(25):975-8. PubMed ID: 6252603 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis A antibodies in liver transplant recipients: evidence for loss of immunity posttransplantation. Arslan M; Wiesner RH; Poterucha JJ; Gross JB; Zein NN Liver Transpl; 2000 Mar; 6(2):191-5. PubMed ID: 10719019 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of GB virus-C/hepatitis G virus infection in patients with cryptogenic chronic liver disease and in patients with primary biliary cirrhosis or Wilson's disease. Tagger A; Ribero ML; Larghi A; Donato F; Zuin M; Chiesa R; Benetti G; Ramella G; Borzio M; Podda M Am J Gastroenterol; 1999 Feb; 94(2):484-8. PubMed ID: 10022651 [TBL] [Abstract][Full Text] [Related]
19. Seroepidemiology of hepatitis A in patients with chronic liver disease. Saab S; Lee C; Shpaner A; Ibrahim AB J Viral Hepat; 2005 Jan; 12(1):101-5. PubMed ID: 15655056 [TBL] [Abstract][Full Text] [Related]
20. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]